GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery
GemPharmatech's NeoMab platform will enable rapid and efficient discovery of fully human therapeutic antibodies against high-value targets. The collaboration aims to shorten antibody development timelines and reduce immunogenicity risks in cancer treatment.